兰德-新的治疗模式及其对NHS的变革潜力-对健康十年计划的见解（英）-2025.6_105页_1mb

Summary of Novel Treatment Paradigms and Their Transformative Potential for the NHS

Overview

This report explores novel treatment paradigms with transformative potential for the National Health Service (NHS) in the UK, focusing on their impact over a ten-year horizon. It covers advancements in biological and health technology treatments, including genomics, synthetic biology, regenerative medicine, and digital health innovations. The analysis highlights opportunities to improve patient outcomes, address public health challenges, and create health and economic benefits.

Key Findings

1. Novel Biological Paradigms:

   • Genomic medicine enables personalized treatments for diseases like cancer and rare disorders, reducing waste and improving patient outcomes.
   • Synthetic biology and gene editing (e.g., CAR-T therapies) offer targeted cancer treatments and vaccines.
   • Regenerative medicine and stem cells show promise for repairing tissues, reducing hospitalizations, and curing conditions like sickle cell disease.

2. Health Technology Innovations:

   • Digital mental health tools, such as apps and virtual reality therapies, improve access to care for conditions like depression and anxiety.
   • Robotic surgery and functional restoration technologies (e.g., brain-computer interfaces) enhance precision, reduce recovery times, and restore mobility.
   • Nanobots and smart pills for targeted drug delivery are in early development but hold potential for precision medicine.

3. Antimicrobial Resistance (AMR):

   • Novel antimicrobials, including bacteriophage therapy, address AMR through alternatives to traditional antibiotics.

4. Timing and Personalised Medicine:

   • Chronotherapy optimizes treatment timing to match biological rhythms, improving efficacy and reducing side effects.

Recommendations: Seven Support Mechanisms

1. Workforce Training: Upskill NHS staff to deliver and adopt novel treatments.
2. Data and Evidence: Invest in data infrastructure and build an evidence pipeline for emerging therapies.
3. Funding and Procurement: Prioritize investments based on technology maturity and potential impact, using flexible demand signals.
4. Regulatory Innovation: Streamline approval processes and establish regulatory sandboxes for new technologies.
5. Physical Infrastructure: Ensure robust facilities for scaling treatments, including genetic modification labs.
6. Collaboration and Coordination: Foster cross-sector partnerships to accelerate research and adoption.
7. Patient and Public Engagement: Address inequalities and build public trust in innovative solutions.

Vision for the Future

In ten years, the NHS could benefit from world-class genomic and synthetic biology infrastructure, expanded regenerative medicine applications, and reduced reliance on traditional resources. Digital tools and AI will enhance care delivery, while time-specific and long-acting treatments will address major public health challenges.